Cronos Group logo

Cronos Group

Stock
Stock
ISIN: CA22717L1013
Ticker: CRON
CA22717L1013
CRON

Price

Price

CHART BY

Frequently asked questions

The market capitalization of Cronos Group is $1.19B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
The Price-to-Earnings (P/E) ratio (TTM) for Cronos Group is 17.55. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
Cronos Group's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $0.254. EPS indicates the company's profitability on a per-share basis.
Currently, 4 analysts cover Cronos Group's stock, with a consensus target price of $3.519. Analyst ratings provide insights into the stock's expected performance.
Over the trailing twelve months, Cronos Group reported a revenue of $247.53M.
Cronos Group's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $14.31M. EBITDA measures the company's overall financial performance.
Cronos Group has a free cash flow of $69.22M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Cronos Group employs approximately 610 people. It operates in the Consumer Staples sector, specifically within the Other Pharmaceuticals industry.
The free float of Cronos Group is 184.88M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$1.19B
EPS (TTM) 
$0.254
Free Float 
184.88M
P/E ratio (TTM) 
17.55
Revenue (TTM) 
$247.53M
EBITDA (TTM) 
$14.31M
Free Cashflow (TTM) 
$69.22M

Pricing

1D span
$3.20$3.27
52W span
$2.291$3.602

Analyst Ratings

The price target is $3.519 and the stock is covered by 4 analysts.

Buy

3

Hold

1

Sell

0

Information

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Stayner, Canada.

Employees
610
Industries
Other Pharmaceuticals
Sector
Consumer Staples

Identifier

ISIN
CA22717L1013
Primary Ticker
CRON

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation